fbpx

Company Profile for Simulations Plus, Inc.

Simulations Plus, Inc., is a premier developer of drug discovery and
development software as well as a leading provider of both preclinical
and clinical pharmacometric consulting services for regulatory
submissions and quantitative systems pharmacology/toxicology models for
drug-induced liver injury and nonalcoholic fatty liver disease. The
company is a global leader focused on improving the ways scientists use
knowledge and data to predict the properties and outcomes of
pharmaceutical, biotechnology, and chemical agents. Our software is
licensed to and used in the conduct of research by major pharmaceutical,
biotechnology, chemical, consumer goods companies, and regulatory
agencies worldwide. Our innovations in integrating new and existing
science in medicinal chemistry, computational chemistry, artificial
intelligence, pharmaceutical science, biology, and physiology into our
software have made us the leading software provider for molecular
property prediction from structure and physiologically based
pharmacokinetic modeling and simulation.

Company:

Headquarters Address:

Main Telephone:

Website:

Home

Type of Organization:

Industry:

Key Executives:

CEO: Shawn O’Connor

Chairman: Walter Woltosz

CFO: John Kneisel

Investor Relations

Contact:

Phone:

Email:

renee@simulations-plus.com

Lancaster Division President

Contact:

Phone:

Email:

john.dibella@simulations-plus.com

CFO

Contact:

Phone:

Email:

johnk@simulations-plus.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20140905005057/en/